Schizophrenia & acute psychosis (first-episode psychosis, acute psychotic episode)
Psychosis · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Positive symptoms (delusions, hallucinations, disorganised speech/behaviour), negative symptoms, and functional decline. Acute psychosis in the ED needs organic exclusion ('first rule out delirium/drugs/structural cause') before psychiatric attribution. ED role: safety, organic workup, treat agitation, urgent early-intervention psychosis referral.
Red flags
- Fever, autonomic instability, seizures, focal neurology, orofacial dyskinesia - think encephalitis (anti-NMDA-R), not primary psychosis
- Rigidity + hyperthermia + raised CK on antipsychotic - NMS
- Command hallucinations to harm self/others; acute suicide risk
- Catatonia (mutism, waxy flexibility) - needs lorazepam challenge
- Rapid-onset psychosis with cognitive decline - image + LP
Assessment
Differential diagnosis
- Delirium (infection, metabolic, post-ictal, intracranial) - key exclusion
- Drug-induced psychosis (stimulants, cannabis, synthetic cannabinoids, hallucinogens, steroids)
- Mania with psychosis / psychotic depression / schizoaffective
- Autoimmune/limbic encephalitis (e.g. anti-NMDA-R), CNS infection, temporal lobe epilepsy
- Dementia with psychosis; Wilson disease in young patients
Investigations
- Full MSE and risk assessment; collateral history; capacity assessment
- FBC, U&E, LFT, TFT, glucose, calcium, CRP, B12/folate; HIV/syphilis if indicated
- Urine/serum toxicology; pregnancy test
- CT/MRI head and consider LP if first episode with atypical/organic features (fever, focal signs, seizures, rapid onset, autonomic instability)
- ECG before antipsychotic (baseline QTc)
Management
- 1. Ensure safety of patient and staff; de-escalate; assess risk and capacity.
- 2. Exclude organic cause (delirium, drugs, encephalitis) - do not anchor on 'psychiatric'.
- 3. Acute severe agitation: rapid tranquillisation per NICE (see acute agitation protocol).
- 4. Start a single oral antipsychotic after discussion (choice guided by side-effect profile).
- 5. Refer urgently to Early Intervention in Psychosis / crisis team; offer CBT and family intervention as part of care.
- 6. Monitor for EPS, NMS, metabolic effects, QTc; baseline weight/lipids/glucose/prolactin.
- 7. Admit if risk, non-adherence, poor support, or diagnostic uncertainty.
Drugs & doses
Olanzapine 10 mg PO OD (5-20 mg) - common first-line, sedating
Risperidone 2 mg PO OD (up to 6 mg; dose-related EPS/hyperprolactinaemia)
Aripiprazole 10-15 mg PO OD - more metabolically neutral, less sedating
Quetiapine 300-450 mg/day - useful if EPS-prone/sensitive [verify local dose]
IM lorazepam 1-2 mg +/- IM antipsychotic for rapid tranquillisation [verify local dose]
Clozapine - only for treatment-resistant schizophrenia under specialist care (agranulocytosis - mandatory FBC monitoring)
Disposition
Urgent psychiatric assessment; admit if risk/non-adherence/organic uncertainty. Early Intervention in Psychosis team for first episode. Medical admission if organic cause suspected.
Complications & pitfalls
- Violence/self-harm; suicide (high lifetime risk in schizophrenia)
- NMS, EPS, acute dystonia, tardive dyskinesia
- Metabolic syndrome, QTc prolongation, hyperprolactinaemia
- Clozapine: agranulocytosis, myocarditis, ileus
Exam pearls
- First-episode psychosis = full organic screen; never assume psychiatric on the first presentation.
- Anti-NMDA-receptor encephalitis mimics acute psychiatric psychosis - watch for seizures, dyskinesia, autonomic signs.
- Early intervention improves prognosis - refer fast.
- One antipsychotic at a time at adequate dose/duration before switching.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.